Vince Wacher
Corporate Officer/Principal bei THERIVA BIOLOGICS, INC.
Profil
Vince Wacher is currently the Head of Corporate and Product Development at Theriva Biologics, Inc. Prior to this, he was the Chief Executive Officer at Verva Pharmaceuticals Ltd.
from 2007 to 2014.
He holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from The University of New South Wales.
Aktive Positionen von Vince Wacher
Unternehmen | Position | Beginn |
---|---|---|
THERIVA BIOLOGICS, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Vince Wacher
Unternehmen | Position | Ende |
---|---|---|
Verva Pharmaceuticals Ltd.
Verva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Verva Pharmaceuticals Ltd. developed therapies to treat diabetes. Its products include insulin sensitizers, insulin secretagogues, fat formation inhibitors for the prevention, treament of obesity, drug-induced weight gain and insulin secretion modulators. The company was founded in 1996 and was headquartered in Geelong, Australia. | Vorstandsvorsitzender | 01.12.2014 |
Ausbildung von Vince Wacher
University of California, Berkeley | Doctorate Degree |
The University of New South Wales | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
THERIVA BIOLOGICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Verva Pharmaceuticals Ltd.
Verva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Verva Pharmaceuticals Ltd. developed therapies to treat diabetes. Its products include insulin sensitizers, insulin secretagogues, fat formation inhibitors for the prevention, treament of obesity, drug-induced weight gain and insulin secretion modulators. The company was founded in 1996 and was headquartered in Geelong, Australia. | Health Technology |